Daniel C. Danila
0000-0002-7647-0741
Publication & Citation Trends
Most Cited Works
Publications
380 total
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study PDF
Cited by 359
OpenAlex
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade PDF
Cited by 655
OpenAlex
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers PDF
Cited by 272
OpenAlex
Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making
Cited by 525
OpenAlex
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer PDF
Cited by 634
OpenAlex
Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer PDF
Cited by 379
OpenAlex
Research Topics
Prostate Cancer Treatment and Research
(305)
Radiopharmaceutical Chemistry and Applications
(76)
Cancer Genomics and Diagnostics
(65)
Cancer, Lipids, and Metabolism
(61)
Cancer Immunotherapy and Biomarkers
(32)
Frequent Co-Authors
Affiliations
Tulane University
Beth Israel Deaconess Medical Center
Royal Marsden NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
NewYork–Presbyterian Hospital